Funding
Diabetes
DIABETES
This project was funded by Diabetes UK (PG 2017/2278). The CONCEPTT trial was funded by JDRF grants #17‐2011‐533, and grants under the JDRF Canadian Clinical Trial Network, a public–private partnership including JDRF and FedDev Ontario and supported by JDRF #80‐2010‐585. Medtronic supplied the CGM sensors and CGM systems at reduced cost. The study sponsor/funders were not involved in the design of the study; the collection, analysis and interpretation of data; writing the report; and did not impose any restrictions regarding the publication of the report. CLM is supported by the Diabetes UK Harry Keen Intermediate Clinical Fellowship (DUK-HKF 17/0005712), a BMA Foundation Award (Helen H. Lawson Award) and the European Foundation for the Study of Diabetes – Novo Nordisk Foundation Future Leaders’ Award (NNF19SA058974). HRM conducts independent research supported by the National Institute for Health and Care Research (NIHR) (Career Development Fellowship, CDF-2013-06-035) and is supported by Tommy’s charity. SF and AK acknowledge funding from the BBSRC (BB/M027252/1). DSF conducts independent research supported by the Canadian Institute for Health Research. This research was supported by the NIHR Cambridge BRC, the core biochemical assay laboratory (CBAL) and the core metabolomic and lipidomic laboratory (CMAL). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.